title: Reversible aggravation of neurological deficits after steroid medication in patients with venous congestive myelopathy caused by spinal arteriovenous malformation.
abstract: Steroids are empirically used to medicate patients with myelopathy of unknown etiology. We report the reversible aggravation of neurological status after steroid administration in a patient with venous congestive myelopathy (VCM). We retrospectively evaluated 36 patients with angiographically confirmed spinal arteriovenous malformation (SAVM) from a prospectively collected neurointerventional database. We evaluated steroid medication and neurological aggravation using Aminoff grading and analyzed using Fisher's exact test whether steroid medication is related to neurological aggravation and spinal cord edema as demonstrated on MR T2-WI. Among 26 patients who had been treated with steroids, ten had aggravated neurological deficits. The aggravation in these ten patients was related to the steroid medication (P = 0.039 in all patients) and only marginally to VCM with spinal cord edema as seen on T2-WI (P = 0.074). Aggravation caused by using a high intravenous dose (250-1000 mg) of methylprednisolone or dexamethasone at 8-20 mg/day slowly decreased after stopping the steroid medication. Steroids were reversibly detrimental in patients with VCM caused by SAVM. A history of neurological aggravation after the use of steroids may suggest the diagnosis of SAVM associated with VCM.
authors.affiliation: Departments of Radiology and Research Institute of Radiology, University of Ulsan, College of Medicine, Asan Medical Center; Seoul, Korea - dcsuh@amc.seoul.kr.
authors.forename: C-S
authors.initials: CS
authors.lastname: Lee
authors.forename: H W
authors.initials: HW
authors.lastname: Pyun
authors.forename: E Y
authors.initials: EY
authors.lastname: Chae
authors.forename: K-K
authors.initials: KK
authors.lastname: Kim
authors.forename: S C
authors.initials: SC
authors.lastname: Rhim
authors.forename: D C
authors.initials: DC
authors.lastname: Suh
references.citation: Anticancer Drugs. 1995 Feb;6(1):19-33
references.pmid: 7756680
references.citation: Rev Neurol (Paris). 2007 Feb;163(2):235-7
references.pmid: 17351543
references.citation: Brain. 1974 Mar;97(1):197-210
references.pmid: 4373119
references.citation: Stroke. 2008 Jan;39(1):105-10
references.pmid: 18063833
references.citation: Radiology. 2002 Mar;222(3):843-50
references.pmid: 11867811
references.citation: Mod Pathol. 2005 May;18(5):710-8
references.pmid: 15578073
references.citation: AJNR Am J Neuroradiol. 2004 Jan;25(1):69-73
references.pmid: 14729531
references.citation: AJNR Am J Neuroradiol. 1991 Nov-Dec;12(6):1077-83
references.pmid: 1763730
references.citation: AJNR Am J Neuroradiol. 2007 Mar;28(3):581-3
references.pmid: 17353341